Iptacopan
ATC L04AJ08 · 9 markets · 12 records
AU 3 records · 2 strengths
- 200 mgcapsuleFABHALTAFABHALTA iptacopan 200 mg hard capsules blister pack
Records without a stated strength · 1 FABHALTA
US 2 records · 1 strengths
- 200 mgcapsuleFABHALTA__no_trade__
GB 1 records · 1 strengths
- 200 mgcapsuleFABHALTA
CA 1 records · 1 strengths
- 200 mgcapsuleFABHALTA
SG 1 records · 1 strengths
- 200 mgcapsuleFABHALTA
ES 1 records · 1 strengths
- 200 mgcapsuleFABHALTA
TW 1 records · 1 strengths
- 200 mgcapsuleFabhalta 200 mg hard capsules服易達200毫克膠囊
HK 1 records · 1 strengths
Records without a stated strength · 1 FABHALTA
EU 1 records · 1 strengths
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Records without a stated strength · 1 FABHALTA
| Strength / form / release | US | GB | CA | AU | SG | ES | TW | HK | EU |
|---|---|---|---|---|---|---|---|---|---|
| 200 mg capsule | No trade name FABHALTA | FABHALTA | FABHALTA | FABHALTA FABHALTA iptacopan 200 mg hard capsules blister pack | FABHALTA | FABHALTA | Fabhalta 200 mg hard capsules 服易達200毫克膠囊 | ||
unknown | FABHALTA | FABHALTA | FABHALTA |
Scroll horizontally for more markets →
Each country column shows the locally registered trade names — not translations.
“not disclosed” means the source does not publish the strength — it does not mean the product has none.
Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.
Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.
EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.